BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15180520)

  • 1. Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins.
    Rivett AJ; Hearn AR
    Curr Protein Pept Sci; 2004 Jun; 5(3):153-61. PubMed ID: 15180520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
    J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of proteasome complexes by gamma-interferon and phosphorylation.
    Rivett AJ; Bose S; Brooks P; Broadfoot KI
    Biochimie; 2001; 83(3-4):363-6. PubMed ID: 11295498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of proteasomes in antigen presentation.
    Gaczynska M; Rock KL; Goldberg AL
    Enzyme Protein; 1993; 47(4-6):354-69. PubMed ID: 7697133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation by MHC class I and its regulation by interferon gamma.
    Früh K; Yang Y
    Curr Opin Immunol; 1999 Feb; 11(1):76-81. PubMed ID: 10047537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.
    Kloetzel PM; Ossendorp F
    Curr Opin Immunol; 2004 Feb; 16(1):76-81. PubMed ID: 14734113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28.
    Tanaka K; Kasahara M
    Immunol Rev; 1998 Jun; 163():161-76. PubMed ID: 9700509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.
    Sijts A; Zaiss D; Kloetzel PM
    Curr Mol Med; 2001 Dec; 1(6):665-76. PubMed ID: 11899255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanism of immunological recognition and the abnormality].
    Tanaka K
    Nihon Rinsho; 1997 Jun; 55(6):1356-62. PubMed ID: 9200918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolysis and class I major histocompatibility complex antigen presentation.
    York IA; Goldberg AL; Mo XY; Rock KL
    Immunol Rev; 1999 Dec; 172():49-66. PubMed ID: 10631936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.
    Kesmir C; van Noort V; de Boer RJ; Hogeweg P
    Immunogenetics; 2003 Oct; 55(7):437-49. PubMed ID: 12955356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.
    Kloetzel PM
    Nat Immunol; 2004 Jul; 5(7):661-9. PubMed ID: 15224091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural plasticity of the proteasome and its function in antigen processing.
    Groettrup M; van den Broek M; Schwarz K; Macagno A; Khan S; de Giuli R; Schmidtke G
    Crit Rev Immunol; 2001; 21(4):339-58. PubMed ID: 11922078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.
    Kloetzel PM; Soza A; Stohwasser R
    Biol Chem; 1999 Mar; 380(3):293-7. PubMed ID: 10223331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.
    De Haan L; Hearn AR; Rivett AJ; Hirst TR
    Infect Immun; 2002 Jun; 70(6):3249-58. PubMed ID: 12011020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?
    Vinitsky A; Antón LC; Snyder HL; Orlowski M; Bennink JR; Yewdell JW
    J Immunol; 1997 Jul; 159(2):554-64. PubMed ID: 9218569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis.
    Teoh CY; Davies KJ
    Arch Biochem Biophys; 2004 Mar; 423(1):88-96. PubMed ID: 14871471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
    Rechsteiner M; Realini C; Ustrell V
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.
    Hendil KB; Khan S; Tanaka K
    Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):749-54. PubMed ID: 9620878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen processing by proteasomes: insights into the molecular basis of crypticity.
    Djaballah H
    Mol Biol Rep; 1997 Mar; 24(1-2):63-7. PubMed ID: 9228283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.